Business
Moderna Tumbles After Nonpartisan Pledge, First Sell Rating – Bloomberg
Moderna Inc. fell 13% on Tuesday after regulators and top drugmakers promised the Covid-19 vaccine approval process would be immune from political pressure and the biotech company drew its first sell rating since going public in 2018.
Moderna Inc. fell 13% on Tuesday after regulators and top drugmakers promised the Covid-19 vaccine approval process would be immune from political pressure and the biotech company drew its first sell rating since going public in 2018.
Moderna’s vaccine is one of three leading candidates Wall Street expects may win an emergency use authorization near-term.. But pledges from the Food and Drug Administration and industry leaders have cast a pall over the prospects of a vaccine being approved befor…
-
Business23 hours ago2 ASX 200 shares to buy and hold for the next decade
-
Noosa News23 hours agoHow to help kids prepare for music exams and competitions and manage performance anxiety
-
General20 hours agoMan arrested after alleged carjackings, dramatic pursuit in Melbourne CBD
-
Noosa News23 hours ago‘Stolen’ Skoda speeds near Dreamworld with police helicopter watching